Rapid relaxation of a hyaluronan matrix may promote invasion by pathological clones
A late-life hyaluronan mimic could promote pathological clone invasion if its matrix loses resistance during sustained cell pulling. In epithelial cultures with fibroblasts, no dependence of invasion on relaxation behavior despite confirmed mechanical changes would refute the proposed mechanism
Stage of verification
- Hypothesis published2026-10-05
- Experiments support key linksAssessed at 6 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Extracellular matrix
Extracellular matrix
The material surrounding cells that transmits and redistributes mechanical loads
Where this hypothesis actsAged precancerous tissues exposed to repeated injury and sustained traction from pathological clones
Hypotheses on this target 11
Protection from degradation
Repair2
Remodelling5
Composition restoration
Crosslink prevention
Tissue graft1
What is proposed
Balance short-term load dissipation with persistent elastic resistance
HowUse high-molecular-weight hyaluronan with a tunable combination of reversible and stable bonds
Possible result
Possible restriction of pathological clone growth and invasion while retaining the proposed benefit in old age
From the recordФизиологический прототип полезного миметика должен включать одновременно рассеяние кратких механических нагрузок и длительно сохраняющуюся упругую составляющую, ограничивающую рост.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
A treatment intended to prolong life might also make it easier for existing abnormal cells to spread through old tissue. The unexpected move is to make protection depend on how long the material around cells resists their pulling, rather than on the length of its molecules alone. This is a pipeline-generated proposal, not a measured result about treatment in old age or lifespan.
- A late-started hyaluronan mimetic is proposed to increase the fraction of surrounding material that quickly loses resistance under sustained deformation.
- After repeated injuries, abnormal cell families pull on and displace that material.
- Rapid relaxation changes the matrix from initially resisting displacement to offering less restoring force while the cells continue pulling.
- The weakened restoring force is proposed to let abnormal cells spread farther despite the hyaluronan chains remaining long.
- Combining bonds that can release and reform with persistent bonds is proposed to absorb brief loads while preserving resistance to prolonged pulling.
- The balance between the matrix's relaxation time and the duration of cell pulling is proposed to determine whether this mechanical effect helps or harms.
Two barriers can feel equally firm at the first push, yet one slowly gives way under continued pressure while the other keeps pushing back. An initial firmness check would miss that difference.
Where the picture breaks: Living cells also alter their surroundings chemically and respond to other cells. The barrier picture explains time-dependent resistance, but cannot establish cell spread or a lifespan effect.
- Master questionstep 01 of 04
Reproducing useful bodily processes could provide new ways to prolong life.
Rests on: The goal calls for proposed mechanisms and substances, combinations or other interventions that could reproduce useful bodily effects.
Stated in the chain - Goal pillarstep 02 of 04
A treatment that imitates a bodily process should retain a dependable margin before its benefits turn into harm.
Rests on: The goal seeks life extension, which requires considering whether an intervention's harmful effects could outweigh its benefits.
Stated in the chain - Gap questionstep 03 of 04
A mimetic, an intervention intended to reproduce a bodily process, would imitate a matrix, the material surrounding cells, made from long-chain hyaluronan, a sugar-chain molecule. The question is whether starting it in old age preserves a lifespan advantage or protects existing pathological clones, families of abnormal cells descended from a common cell, enough to cause harm after repeated injuries.
Rests on: The preceding stage supplies the concern about benefit turning into harm, but does not identify this material or this route to harm.
LeapThe supplied chain does not establish an earlier lifespan advantage for this mimetic or why protection of existing abnormal cell families is the relevant route by which it would be lost. The screened sources do not supply those missing links.
- Hypothesisstep 04 of 04
Long hyaluronan chains might permit faster invasion, the spread of abnormal cells into surrounding material, if the matrix undergoes rapid stress relaxation, meaning its resisting force falls while it remains deformed. The proposed protective material would absorb brief loads while retaining an elastic component, a lasting tendency to recover its shape, during prolonged cell pulling.S3
Rests on: The gap supplies the late-treatment and repeated-injury setting. S3, published in Advanced Materials in 2024, reports faster invasion by glioblastoma cells, cells from an aggressive brain cancer, in rapidly relaxing long-chain hyaluronan hydrogels, water-rich laboratory gels, than in shorter-chain gels. That comparison supports part of the mechanical premise, but does not establish the proposed effect at matched chain length or its consequences in old tissue after repeated injuries.
Supported by literature
What is carried, and what is not. Screened sources speak directly to parts of two proposed links: relaxation accompanying faster invasion in S3, and relaxation facilitating cell spreading in S7, a 2018 Biomaterials study that does not establish invasion after injury; S5 is the corresponding 2024 bioRxiv preprint and is not independent replication. Nothing supplied establishes the sequence through late treatment, repeated injury and lifespan, and the direction is not uniform across systems: S4 in Science Advances in 2026 reports more clustering and a protein signal associated with invasion in slowly relaxing materials without settling actual invasion speed, while the available abstract of S6 in Acta Biomaterialia in 2021 reports reduced migration with long-chain hyaluronan in collagen, a structural protein, without testing the proposed relaxation-and-pulling relationship.S3S7S5S4S6
Where the reasoning is carried by something unstated · 1
- Gap question. The supplied chain does not establish an earlier lifespan advantage for this mimetic or why protection of existing abnormal cell families is the relevant route by which it would be lost. The screened sources do not supply those missing links. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Greater spread could be attributed to relaxation even if changing the bonds also changes hyaluronan chain lengths, concentration, initial stiffness or access to sites through which cells interact with the material. The long-chain versus short-chain comparison reported in S3 does not by itself separate these possibilities.S3 What closes it: The proposed matching of those properties must be verified experimentally. Both the loss of resistance over time and the resistance that persists must be measured, together with the duration of cell pulling.
- Cell clustering or a protein signal associated with invasion could be mistaken for cells actually spreading farther. A negative result could also reflect pulling episodes too short to reveal the predicted difference. What closes it: Measure actual movement into surrounding material and compare short with sustained pulling against the measured relaxation times. Define the invasion measure and the required mechanical contrast before the comparison.
- A difference in spread could be credited to mechanics even if one of the competing biological routes remains active. Conversely, a result in a simplified culture could be read as proving that mechanics dominates harm in an injured organism. What closes it: The specified culture contains epithelial cells, cells that form tissue linings, and fibroblasts, cells that produce and reshape surrounding material. Its exclusion of fusion with macrophages, immune cells that engulf material, and of extracellular histones, normally DNA-packaging proteins released outside cells, must be verified. The design must also establish whether the rival route involving protein attachment to hyaluronan and altered immune-cell behavior is absent or controlled; even successful isolation would not rank these routes in old tissue.
What would make this wrong. The proposed mechanical chain would fail if verified changes in relaxation and persistent elasticity produced no corresponding difference in actual invasion under matched composition, initial stiffness and cell-interaction conditions, with sustained pulling sufficient to expose the predicted effect and competing routes excluded. That observation would reject this proposed explanation; it would not establish which rival explanation is correct.
What it would change. If the prediction held, selecting a bodily-process mimetic for possible life extension would require attention to how its resistance changes during sustained cell pulling, alongside its chemical composition. Long hyaluronan chains alone would not establish the proposed mechanical protection. A successful culture test would still leave unestablished whether the effect occurs in old tissues after repeated injuries, whether it outweighs the competing routes, and whether it changes lifespan.
Sources read · 8
Mechanically matching the rheological properties of brain tissue for drug-delivery in human glioblastoma models. · Biomaterials · 2021
“The mechanical and viscoelastic properties of native human and mouse tissues are measured over 8 h via oscillatory rheology under physiological conditions.”
Does not settle: Источник не устанавливает, как время релаксации гиалуронанового матрикса влияет на инвазию патологических клонов, клеточную тягу или возвращающую силу. Также он не сравнивает обратимые и устойчивые связи и не оценивает роль молекулярной массы гиалуронана.
Bioengineered Scaffolds for 3D Analysis of Glioblastoma Proliferation and Invasion. · Annals of biomedical engineering · 2015
“Proliferative and invasive behaviors were observed to be contingent on cell type, gel stiffness, and hepatocyte growth factor availability.”
Does not settle: Источник не устанавливает влияние времени релаксации матрикса, длительности клеточной тяги, молекулярной массы гиалуронана или соотношения обратимых и устойчивых связей на инвазию. В аннотации описана только зависимость поведения двух линий клеток глиобластомы от жесткости гидрогеля и других условий за 14 дней.
Viscoelastic High-Molecular-Weight Hyaluronic Acid Hydrogels Support Rapid Glioblastoma Cell Invasion with Leader-Follower Dynamics. · Advanced materials (Deerfield Beach, Fla.) · 2024
“Unlike LMW HA hydrogels, HMW HA hydrogels relax stresses quickly, to a similar extent as brain tissue, and to a greater extent than many conventional HA-based scaffolds. GBM cells implanted within HMW HA hydrogels invade much more rapidly than in their LMW HA counterparts and exhibit distinct leader-follower dynamics.”
Does not settle: Открытыми остаются последствия повторных повреждений и позднего введения миметика, роль сочетания обратимых и устойчивых связей, сохранение длительной упругой составляющей, а также зависимость пользы от соотношения времени релаксации матрикса и длительности тяги клона. Исследование рассматривает инвазию клеток глиобластомы в гидрогелях in vitro, поэтому перенос результата на другие патологические клоны и ткани не установлен.
Matrix stress relaxation drives glioblastoma cell response in viscoelastic biomaterials. · 2026
“Slow stress-relaxing matrices promote cell clustering and elevated expression of P-selectin, a GBM invasion marker.”
Does not settle: Остаются открытыми фактическая скорость инвазии, влияние повторных повреждений, роль молекулярной массы гиалуронана, оптимальное сочетание обратимых и устойчивых связей, соотношение времени релаксации и длительности клеточной тяги, а также перенос результатов на ткани in vivo.
Viscoelastic high-molecular-weight hyaluronic acid hydrogels support rapid glioblastoma cell invasion with leader-follower dynamics. · bioRxiv : the preprint server for biology · 2024
“Unlike LMW HA hydrogels, HMW HA hydrogels relax stresses quickly, to a similar extent as brain tissue, and to a greater extent than many conventional HA-based scaffolds. GBM cells implanted within HMW HA hydrogels invade much more rapidly than in their LMW HA counterparts and exhibit distinct leader-follower dynamics.”
Does not settle: Источник описывает инвазию клеток глиобластомы в гидрогелях in vitro. Он не устанавливает последствия повторных повреждений, влияние позднего введения миметика, причинную роль соотношения времени релаксации и длительности клеточной тяги, а также пользу сочетания обратимых и устойчивых связей.
Cancer cell migration in collagen-hyaluronan composite extracellular matrices. · Acta biomaterialia · 2021
“HA appears to have the effect of decreasing migration and increasing collagen network contraction, but only at high HA molecular weight.”
Does not settle: The abstract does not test stress-relaxation times, sustained cellular traction, repeated injury, pathological clonal invasion, or matrices combining reversible and stable crosslinks, so it does not establish whether rapidly relaxing high-molecular-weight HA accelerates invasion under the proposed conditions.
Stress relaxing hyaluronic acid-collagen hydrogels promote cell spreading, fiber remodeling, and focal adhesion formation in 3D cell culture. · Biomaterials · 2018
“Faster relaxation in the IPN hydrogels promotes cell spreading, fiber remodeling, and focal adhesion (FA) formation - behaviors often inhibited in other hydrogel-based materials in 3D culture.”
Does not settle: Источник не устанавливает, ускоряет ли быстрая релаксация инвазию патологических клонов после повреждения. Он также не определяет необходимое соотношение времени релаксации и длительности клеточной тяги, роль длительно сохраняющейся упругости, влияние высокой молекулярной массы гиалуронана на инвазию и применимость результатов к тканям организма.
Hyaluronan (HA)-inspired glycopolymers as molecular tools for studying HA functions. · RSC chemical biology · 2021
“Herein, glycopolymers bearing single or alternating HA monosaccharides have been synthesised and used as synthetic tools to dissect the binding of HA to known and new proteins and as potential HA-mimetic therapeutics.”
Does not settle: Источник не устанавливает влияние времени релаксации гиалуронанового матрикса на инвазию патологических клонов, связь между длительностью клеточной тяги и возвращающей силой, а также оптимальное сочетание обратимых и устойчивых связей.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does starting a tissue-matrix mimic in old age extend life, or shorten it by protecting abnormal cells after repeated injuries?
Original wording · exactly as the pipeline generated it
Сохраняет ли миметик высокомолекулярного гиалуронанового матрикса преимущество продолжительности жизни при запуске в старости, или защита уже существующих патологических клонов обращает пользу во вред после повторных повреждений?
What this question is asking
The question concerns whether imitating a tissue-supporting material remains beneficial when treatment begins in old age. The proposed intervention would reproduce properties of a matrix containing long chains of hyaluronan, a substance found around cells. It asks whether treated older organisms live longer than otherwise comparable untreated organisms, including after repeated injuries and during later follow-up, or whether treatment instead protects existing groups of abnormal cells and shortens life. The question assumes an earlier lifespan benefit in genetically modified mice, but the supplied sources do not establish that result or its transfer to a mimic started in old age. No particular mimic, target species, or starting age is specified.
- Tissue matrix
- Material surrounding cells that forms part of their local environment. Here, the proposed intervention would imitate properties of a matrix containing hyaluronan.
- Mimic or mimetic
- An intervention intended to reproduce selected properties or effects of something else. No specific intervention is supplied here, so equivalence to hyaluronan treatment or genetic modification is not established.
- Hyaluronan
- A long-chain sugar molecule found in the material around cells. The supplied sources discuss both recovery after injury with long-chain hyaluronan and elevated hyaluronan or its fragments in certain cancers; those observations do not establish a single uniformly beneficial or harmful effect.
- High-molecular-weight hyaluronan
- Hyaluronan made of relatively long molecular chains. This names a size class rather than one uniquely defined molecule; the supplied material gives no numerical boundary for that class.
- Pathological clone or abnormal cell group
- A group of cells descended from a common cell and carrying a disease-related abnormality. The question concerns groups already present before treatment, but does not identify their abnormalities or establish that all such groups cause cancer.
- Pathological selection
- A process in which conditions favor the survival or expansion of disease-related cell groups over other cells. The pipeline asks whether repeated treatment and injury permit this process, but the supplied sources do not measure it.
- Transgenic mice
- Mice whose genetic material has been deliberately altered by introducing genetic material. The pipeline invokes a lifespan result in such mice without supplying the relevant study or identifying the alteration.
- Remaining lifespan
- The time lived after an intervention begins. In this question, it must include later consequences rather than only recovery immediately after injury.
- Halogens and chlorine
- Halogens are a family of chemical elements that includes chlorine. S3 and S4 concern lung or airway injury after exposure to chemicals from this family.
- Calcium ions
- Electrically charged calcium particles that can participate in signals within cells. S3 reports reversal of an increase after treatment, without establishing a connection to lifespan.
- Ras homolog family member A
- A signaling protein, conventionally abbreviated RhoA. S3 reports that treatment reversed its activation after chemical exposure; the supplied evidence does not connect that change to abnormal-cell protection.
- Airway hyperresponsiveness
- An excessive airway response to stimulation, conventionally abbreviated AHR. It is an airway-function outcome in S3, not a measurement of lifespan.
A high-molecular-weight hyaluronan matrix mimic has a lifespan advantage to preserve, based on reported lifespan extension in transgenic mice.
Hyaluronan is a material around cells, and high-molecular-weight hyaluronan consists of relatively long molecular chains. The question invokes longer life in mice whose genetic material was deliberately altered and assumes that an intervention imitating this surrounding material could reproduce that benefit. That assumption supplies the starting benefit whose persistence in old age is being questioned.
The pipeline states that genetically modified mice lived longer, but the study behind that statement is not among the supplied screened sources. S3 and S4 concern treatment with high-molecular-weight hyaluronan after chemical lung injury; neither establishes lifespan extension or equivalence between that treatment and a matrix mimic. S1 concerns hyaluronan in cancer and also does not establish the claimed lifespan benefit. This small set of background sources is insufficient to judge the premise; the missing supporting study does not make the premise false.S1S3S4
The same question asked without the part nothing read establishes:
- Does a high-molecular-weight hyaluronan matrix mimic started in old age increase or decrease remaining lifespan after repeated injuries?
- Does a high-molecular-weight hyaluronan matrix mimic protect existing abnormal cell groups after repeated injuries in old tissue?
- Remaining lifespan increases Under the proposed mechanism, tissue protection would outweigh any harmful protection of abnormal cells through repeated injuries and later follow-up. A longer remaining lifespan would establish a favorable overall outcome under those conditions, but would not by itself show that abnormal cells were unaffected.
- Remaining lifespan decreases through abnormal-cell protection Under this branch, the intervention would preserve existing abnormal cells, allowing their persistence or expansion after repeated injuries to cause enough harm to outweigh tissue protection. Improved recovery from an individual injury would then give an incomplete picture of the intervention's overall effect.
- Remaining lifespan does not change Tissue protection might fail to affect survival, or beneficial and harmful effects might balance. An unchanged lifespan alone would not distinguish those explanations or establish whether abnormal cells were protected.
The proposed benefit depends on a sequence: changing the material around cells would protect tissue, that protection would preserve function through injury, and the resulting effects would increase remaining lifespan. The proposed harm follows a different sequence: protection would also preserve abnormal cells, those cells would persist or expand through repeated injuries, and their effects would outweigh the tissue benefit. These are the question's competing possibilities, not findings established by the supplied sources. Treating recovery from an immediate injury as proof of longer life could therefore mistake a short-term benefit for a favorable lifetime outcome.
сообщает продление жизни трансгенных мышей уровня RL-2; поздний запуск при существующих патологических клонах не проверен.
Повторное действие миметика ограничивает патологический отбор и сохраняет положительный баланс оставшейся жизни, включая отсроченный период.
Требуется опровергающая проверка переноса пользы на старую клонально изменённую ткань при сохранённом воздействии на гиалуронановый матрикс.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Поздний гиалуронановый миметик может обращать пользу во вред, если увеличивает долю матрикса, способного быстро расслаблять напряжение под длительной тягой клеток. После каждого повреждения патологический клон раздвигает такой матрикс, а релаксация ослабляет возвращающую силу. Сохранение высокой молекулярной массы тогда совместимо с ускоренной инвазией. Физиологический прототип полезного миметика должен включать одновременно рассеяние кратких механических нагрузок и длительно сохраняющуюся упругую составляющую, ограничивающую рост. Кандидат представляет собой высокомолекулярный гиалуронан с регулируемым сочетанием обратимых и устойчивых связей. Его предполагаемая польза зависит от соотношения времени релаксации матрикса и длительности тяги клона.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Неравновесная термодинамика пассивных вязкоупругих сред. В локальном изотермическом приближении неравенство Клаузиуса-Дюгема имеет вид D = σ·dε/dt - dψ/dt ≥ 0. Здесь D представляет плотность мощности механической диссипации в матриксе, σ означает измеренное локальное напряжение, ε означает деформацию, t означает время, ψ означает плотность запасённой свободной энергии. Для замкнутого цикла, возвращающего матрикс к тому же состоянию, W_diss = V∮σ dε = TΔS_i ≥ 0: V представляет исследуемый объём, W_diss представляет рассеянную работу, T представляет абсолютную температуру ткани, ΔS_i представляет произведённую энтропию. В линейном колебательном опыте W_diss/V = πG''(ω)ε₀², где G'' означает модуль потерь, ω означает угловую частоту нагрузки, ε₀ означает амплитуду деформации. Проверяемая модель релаксации: σ(t) = ε₀[G∞ + G₁ exp(-t/τ)], где G∞ представляет сохраняющийся упругий модуль, G₁ представляет релаксирующую составляющую, τ представляет её время релаксации. Все механические параметры определяются реологией и локальной микромеханикой. Ограничение относится к пассивной части матрикса; активную работу клеток и химическое ремоделирование учитывают отдельно.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковых концентрации и распределении длины гиалуронана, начальной жёсткости и доступности рецепторных участков быстро релаксирующий матрикс позволит клонам распространяться дальше, чем матрикс с устойчивой упругой составляющей. Различие сохранится в культуре эпителия с фибробластами при исключённых слиянии с макрофагами и внеклеточных гистонах. Переход от коротких к длительным эпизодам клеточной тяги усилит различие в соответствии с измеренным временем релаксации. Отсутствие зависимости инвазии от релаксационного спектра при подтверждённом изменении механики опровергнет эту гипотезу.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies comparative clone spread under matched conditions, a change with traction duration, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Гиалуронановые гидрогели с регулируемыми обратимыми связями позволяют менять релаксацию и упругость. В модели глиобластомы уже наблюдали более быструю инвазию в релаксирующих высокомолекулярных гиалуронановых гелях. Перенос на старые предопухолевые ткани и продолжительность жизни остаётся гипотезой. [Исследование инвазии в гиалуронановых гидрогелях](https://pmc.ncbi.nlm.nih.gov/articles/PMC11637900/).
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковых концентрации и распределении длины гиалуронана, начальной жёсткости и доступности рецепторных участков быстро релаксирующий матрикс позволит клонам распространяться дальше, чем матрикс с устойчивой упругой составляющей. Различие сохранится в культуре эпителия с фибробластами при исключённых слиянии с макрофагами и внеклеточных гистонах. Переход от коротких к длительным эпизодам клеточной тяги усилит различие в соответствии с измеренным временем релаксации. Отсутствие зависимости инвазии от релаксационного спектра при подтверждённом изменении механики опровергнет эту гипотезу.
- What would separate them
Hyaluronan mimetics may extend late-life survival by blocking cell fusion predicts: У старых мышей с заранее меченными патологическими клонами миметик уменьшит число клеток, содержащих подтверждённые ядерные генетические метки обеих родительских линий, и частоту инвазивных опухолей при сопоставимой численности исходных мутантных клеток. Введение заранее полученных и генетически подтверждённых гибридов обойдёт защиту миметика. Если слияние независимо подавлено при сохранённых фагоцитозе и иммунной цитотоксичности, дополнительный противоопухолевый эффект гиалуронана почти исчезнет. Сохранение полной защиты после введения гибридов опровергнет предполагаемое ведущее звено.
- Rival 02 of 03What would separate them
Protein attachment to hyaluronan may shield abnormal cells by altering macrophage activity predicts: При одинаковых длине цепей и измеренной механике матрикса клоны будут сохраняться лучше в присутствии гиалуронана с ковалентно присоединёнными тяжёлыми цепями. Избирательное подавление трансферазной функции TSG-6 восстановит удаление патологических клеток, а добавление заранее сформированного комплекса вернёт их защиту. Эффект должен сопровождаться изменением активности макрофагов при сопоставимых числе контактов с мишенями и частоте клеточного слияния. Если различие исчезает после выравнивания механики, преимущество получает гипотеза диссипации.
- What would separate them
Hyaluronan may preserve late-life benefit by binding extracellular histones predicts: Избирательная нейтрализация внеклеточных гистонов воспроизведёт защиту нормальных соседей и существенно уменьшит дополнительный эффект гиалуронана. Защита сохранится в культуре с исключённым слиянием клеток и подавленным переносом тяжёлых цепей. При одинаковой механике матрикса выраженность эффекта будет следовать за снижением свободной цитотоксичной фракции гистонов. Если гиалуронан по-прежнему ограничивает клональный рост после практически полного устранения этой фракции, гипотеза теряет статус основного объяснения.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.